15(1-55)
16(1-54) 11 (1-55) 20 (1-48) *Significantly more men in this grotup compared with other groups (p=0O006).
A total of 865 patients were circulated and 630 (72%) replied. Some 28 (4%) had continued to use glass syringes, 151 (24%) had used plastic syringes before the changeover, and 451 (72%) had chosen plastic syringes for the first time; 548 (87%1) thought that administration of insulin was easier with UI00 insulin (table) .
Glass syringes lasted a mean of 10 months, equivalent to an annual usage of 1 21 svringes. The needles used with them lasted a mean of 31 8 injections (steel) and 9-9 injections (disposable). Some 406 (90°%) patients using plastic syringes preferred them and used them for an average of 14 2 injections. No patient reported infection at the injection site. The most common reasons for discarding syringes were: blunting of the nccdle; bending of the needle; fading of markings; simple preferencc; hospital instructions; and hygiene.
Comment
This seems to be the largest reported survey of use of insulin syringes,f and the high response rate of 72% is sufficient for valid statistical analysis. We confirm the feasibility and safety of multiple reuse of plastic syringes. The number of glass syringes used annually (1 -21) was similar to that reported in another large study (1 72).
Current district costs are £6 67 for a glass syringe and non-disposable needle, compared with 9-5p for a Becton-Dickinson plastic syringe. This gives an annual cost for patients having twice daily injections of £12 91 with glass syringes and £4-72 with plastic syringes and for patients having once daily injections £1049 and £2 36, respectively. By reusing plastic syringes a calculated minimum saving of £7000 a year has been made in the Southampton district, not including savings from not providing spare glass syringes, carrying cases, industrial spirit, and cotton wool. Reuse of plastic syringes as described could provide savings of over £0 5 million a year for the United Kingdom as a whole.
Issuing plastic syringes on the drug tariff through a hospital pharmacy could ensure the safe and economical reuse of syringes. There is no sound basis for continuing to advise single use of plastic insulin syringes. A new resuscitation apparatus providing 70% oxygen Mouth to mouth ventilation is still the most simple first line resuscitation manoeuvre recommended to the non-anaesthetist.' Any proposed improvement on this technique must be straightforward and foolproof. We report on the performance of a simple apparatus that allows oxygen to be administered during both spontaneous and "expired air powered" ventilation. It also overcomes some of the problems inherent in other methods of resuscitation.
The apparatus
The apparatus (figure) consists of an Ambu E valve that may be attached to any facemask with a 22 mm socket or to any endotracheal tube connector of 15 mm taper. The expiratory port has a 30 mm taper, which will not connect to any of the other components. A Y piece (Siemens, 66 05 729 E037E) and a flexible, corrugated 1-5 m tube (Hudson, 1417) provide a 500 ml oxygen reservoir, with a terminal 22 mm taper, on to which fits a disposable mouthpiece (Ohmeda, 332555). The oxygen connecting tube (Argyle, 8888-230409) fits onto a 15 mm Thc ncw resuscitation apparatus.
endotracheal tube connector (Portex, 100/252/080) and is an essential part of the system. It has a high resistance to gas flow, which ensures that satisfactory ventilation is maintained even if it is not connected to (or becomes disconnected from) a supply of oxygen. All joints except those to the Ambu valve and mouthpiece are permanently bonded together by cyanoacrylic adhesive (Loctite 406). Laboratory evaluation-End tidal carbon dioxide pressure and mean oxygen concentration at the mouth were measured using a Datex Normocap (CD102/02) carbon dioxide and oxygen analyser. Healthy volunteers ventilated spontaneously through the apparatus at 12 breaths per minute, to an end tidal carbon dioxide pressure of 33-40 mm Hg. With oxygen flows of 2, 6, and 10 I/min mean oxygen concentrations at the mouth were 34-6%, 69-3%. and 80-5%, respectively, after two minutes.
Clinical evaluation-Seventeen patients (10 male and seven female) aged between 3 and 79 were studied during general anaesthesia. They were ventilated using the apparatus with an oxygen inflow of 10 1/min to an end tidal carbon dioxide pressure of between 30 and 42 mm Hg. The mean oxygen concentration at the mouth was 80 6% (range 72-94%) after two minutes.
Comment
The self inflating bag with non-rebreathing valve, facemask, and oropharyngeal airway is traditionally used to provide high oxygen concentrations during resuscitation. Alkaline phosphatase KAU/1 (normal=20-1 10) 100 100 90 100
Alanine transferase (IU/l) (normal <20) 15 95 27 13
Conversion: SI to traditional units-Bilirubin: 1 tmol/1-006 mg/100 ml.
tonsillitis. He had never had jaundice or hepatitis, but three months earlier his regular partner had acute hepatitis B virus infection. On examination there was generalised lymphadenopathy with firm, nontender nodes 1-2 cm in diameter. Ocular examination showed visual acuities corrected with glasses of 6/18 (for distance) N5 (for near vision) on the right and 6/5 N5 on the left, his colour vision, pupillary reactions, and extraocular movements being normal. There was a central scotoma in the right field but the left was full, and there were cells in the anterior vitreous bilaterally. Both fundi showed noticeable disc swelling, dilated capillaries, arterial sheathing, haemorrhage in the nerve fibre layer, retinal pigment epithelial change, and macular star formation.
Investigations showed haemoglobin concentration 1-42 g/l, white cell count 6 6x 109/l with 50% lymphocytes with atypical lymphocytosis, negative results from Paul Bunnell test, negative syphilis serology, the presence of hepatitis B surface antigen and hepatitis B e antigen (table), and the following viral titres: Epstein Barr virus IgG 1/20, IgM 1/8; cytomegalovirus IgG 1/32, IgM negative; and toxoplasmosis 1/16. The'se titres remained unchanged at three months. The table gives the results of liver function tests. A computed tomogram of the brain was normal and a cervical node biopsy showed reactive hyperplasia.
The patient remained well without jaundice, and his lassitude, lymphadenopathy, visual function, and serological results improved steadily (table) . When examined six months after presentation he had minimal lymphadenopathy and ocular examination was normal.
Stored serum samples were subsequently examined for antibodies to the human T lymphotropic virus type III/lymphadenopathy associated virus (HTLV-IIIILAV). A serum sample taken in January 1983 was negative, but a sample taken in December 1983 was positive. He admitted to having had several new sexual partners between August and December 1983.
Viral disease may be associated with papillitis with or without evidence of intraocular inflammation.' Papillitis has been reported in association with rubella,2 herpes zoster,3 chicken pox, mumps, influenza, poliomyelitis, coxsackie virus,' and infectious mononucleosis.4 One patient reported by Walsh and Hoyt exhibited bilateral optic neuritis after hepatitis B virus infection but suffered persistent disturbance of his colour vision, and the role of hepatitis in the development of his optic neuritis was uncertain.5
Our patient had unequivocal clinical and serological evidence of acute hepatitis B infection with an identical time course to the development of papillitis. there were no clinical features of demyelination or raised intracranial pressure.
Lymphadenopathy is common in the early stages of acute hepatitis B infection. As our patient was homosexual it was thought, initially, that his lymphadenopathy might have been unrelated to hepatitis B infection and represented a concurrent persistent lymphadenopathy syndrome secondary to HTLV-III/LAV infection. The subsequent finding of antibodies to HTLV-III/LAV could mean that the patient was immunocompromised at the time of his acute hepatitis B infection and perhaps staged an exaggerated lymph node response because of this. He was, however, negative for HTLV-III/LAV antibodies at presentation, and the lymphadenopathy, ocular features, and immunological abnormalities all cleared after resolution of his acute hepatitis B infection. Although he may have had seronegative HTLV-III/LAV infection, it seems more likely that he acquired HTLV-III/LAV infection when he became sexually active again.
This patient had acute papillitis and lymphadenopathy coincident with serological evidence of acute hepatitis B virus infection. This suggests-that hepatitis B virus may be associated with the development of papillitis.
